UnitedHealth Falls 5.4% on CMS's CRUSH Audit Plan, With $385.23 the Next Test

Source Tradingkey

TradingKey - UnitedHealth Group (NYSE: UNH) fell 5.42% to $389.68 on Tuesday, November 17, from $412.02, on volume of about 8 million shares, well above its 5.2 million average. Premarket quotes are slightly lower at $387.91, and the stock is now about 16% below its 52-week high of $461.62.

The drop came a day after the Centers for Medicare & Medicaid Services, or CMS, the agency that runs Medicare, proposed a sweeping anti-fraud rule that would bring back tougher audits of Medicare Advantage insurers. Other insurers fell too, with Humana down 5.48% and CVS Health down 3.48%.

What the CRUSH Rule Would Change

On November 16, CMS proposed the Comprehensive Regulations to Uncover Suspicious Healthcare, or CRUSH, rule, which it says would save nearly $90 billion in federal spending over the next decade. The part that matters most for UnitedHealth covers risk adjustment data validation audits, known as RADV audits, which check whether insurers were overpaid based on how sick their members appeared in medical records.

Under the proposal, audit findings from a small sample of members would be extrapolated, meaning applied across an insurer's entire contract, starting with payment year 2018. CMS would also drop the fee-for-service adjuster, a discount that has protected insurers by allowing for coding errors that also happen in traditional Medicare. CMS estimates the change would recover an average of about $9 billion in Medicare Advantage overpayments per payment year across the industry.

The rule would also make fraud reporting mandatory. Only 46% of Medicare Advantage and drug plans voluntarily reported suspected fraud last year. Providers that bill Medicare Advantage plans would have to enroll in traditional Medicare two years after the final rule is published. Comments are due by January 19, 2027.

Why UnitedHealth Is Most Exposed

UnitedHealth is the largest Medicare Advantage insurer, so wider audits reaching back to 2018 could mean repayments for past years and tighter risk coding, the way insurers record how sick members are, which affects how much Medicare pays them. The company has not yet quantified any exposure, and GuruFocus said investors will watch whether it reserves for its 2018 to 2024 audit risk before the comment period closes.

The rule also has a legal history. CMS's 2023 audit rule allowed extrapolation and dropped the same adjuster, but a federal judge in Texas vacated it in September 2025 after a lawsuit by Humana, finding CMS had not given proper notice. HHS appealed in November 2025, and the Fifth Circuit heard arguments in October. CRUSH would effectively re-propose parts of that rule, so the final impact depends on both the appeal and the comment process.

The Recovery Story Was Going Well

The timing hurts because UnitedHealth's turnaround had been working. Third-quarter adjusted EPS rose to $4.69 from $2.92, against a $4.14 consensus, and UnitedHealthcare's operating margin improved to 3.3% from 2.1%. The company raised its 2026 adjusted EPS outlook to at least $20.50, from $19.50 to $20.00, its third raise of the year, and management targets 13% to 16% annual EPS growth over time.

For 2027, UnitedHealth is focusing on markets and products with more durable margins, including special needs plans for seniors with complex health needs, and about 390,000 members are in Medicare Advantage plans it is discontinuing. The Justice Department's criminal and civil probes into its Medicare Advantage billing also remain unresolved.

Analysts were still positive before the selloff. The average target is about $469.77, according to TradingKey data, about 21% above Tuesday's close, with Wells Fargo at $487 and JPMorgan at $524. At $389.68, the stock trades at about 19 times the $20.50 EPS floor, by my calculation. That multiple now has to absorb a new regulatory risk that the company cannot yet measure.

UnitedHealth Technical Analysis: 4-Hour Close Below $385.23 Could Open $373.77

That shift shows clearly on the 4-hour chart. The stock has just slipped below the rising trendline, a line drawn under its higher lows, that supported it since early October. Sellers stepped in again near $410.51, the 50% Fibonacci retracement of the July to October drop, which has capped rallies for most of November. The drop also pushed price below both moving averages, which track the average price over recent sessions, at $397.61 and $400.96, so the short-term picture now favors sellers.

RSI, a momentum gauge that runs from 0 to 100, has fallen to about 38, below its signal line. The MACD, another momentum indicator, has also turned slightly negative, which confirms that momentum is fading.

UNH Price Chart - Source: Tradingview

UNH Price Chart - Source: Tradingview

The key support is $385.23. A 4-hour close below it could send the stock toward $373.77, followed by $362.74, the October low. For buyers, reclaiming $399.37 would cancel the breakdown and could reopen $410.51.

I'm cautiously bearish while UnitedHealth stays below $399.37, with $385.23 as the next test.

Key Levels

  • Last close: $389.68, down 5.42% on Tuesday, November 17 (premarket: $387.91)
  • Support: $385.23, $373.77, $362.74
  • Resistance: $397.61, $399.37, $410.51
  • RSI: 38.25
  • Bullish trigger: 4-hour close above $399.37
  • Bearish trigger: 4-hour close below $385.23

FAQs

Why did UnitedHealth stock fall?

UnitedHealth fell 5.42% after CMS proposed the CRUSH rule, which would revive wider Medicare Advantage audits reaching back to 2018 without the fee-for-service adjuster, a change CMS estimates would recover about $9 billion a year industrywide.

What is the UnitedHealth stock forecast now?

The bias is cautiously bearish while UNH stays below $399.37. A 4-hour close below $385.23 could send the stock toward $373.77 and $362.74, while reclaiming $399.37 would cancel the breakdown and could reopen $410.51.

Bottom Line

UnitedHealth's earnings recovery is intact, but the CRUSH proposal adds a regulatory risk that investors cannot yet size. The level that matters is $385.23. In my view, a 4-hour close below it would open the way toward $373.77, while a move back above $399.37 would show the market sees the audit threat as manageable.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Anthropic is six times oversubscribed at $1.4 trillion while Nvidia is down 32% — the AI trade has two pricesAnthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
Author  Irene Q.
Nov 16, Mon
Anthropic lists on Nasdaq as ANT on Thursday at $70 ~ $78 a share, raising up to $64.4 billion at a target valuation near $1.4 trillion, and the book is reportedly six times covered. In the same six weeks, Nvidia has fallen 32% and the QQQ is 10.9% below its October peak. Private capital and public markets are marking the same AI complex at two very different prices. This piece separates the two books: what the S-1 shows, who is anchoring the $26 billion private placement, and what Thursday's debut would have to do to change the public tape.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 16, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 16, 2026. Read on for the details.
Author  Mitrade
Nov 16, Mon
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 16, 2026. Read on for the details.
placeholder
Weekly Report: DXY 103.41, 10-year 5.15%, AUD carry 3bp — three FX regimes flipped in one weekThe dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
Author  Irene Q.
Nov 16, Mon
The dollar index rose 1.09% to 103.41, a 19-month high, while the US 10-year closed at 5.154% and the Australia-US two-year spread collapsed to about 3 basis points from 36. EURUSD fell 1.59% to 1.1024, USDJPY rose 1.51% to 159.78 and AUDUSD fell 1.79% to 0.6764, a 10-month low. Three FX regimes — the broad dollar, the US rate level and the Australian carry premium — flipped in the same week. This report marks the thresholds, ranks which one can flip back first, and lists the week's calendar.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 17, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
Author  Mitrade
Yesterday 05: 40
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 17, 2026. Read on for the details.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 18, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 18, 2026. Read on for the details.
Author  Mitrade
8 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 18, 2026. Read on for the details.
goTop
quote